Back to Search
Start Over
0372: Impact of exercise mitral regurgitation on hypertrophic cardiomyopathy outcomes
- Source :
- Archives of Cardiovascular Diseases Supplements, Archives of Cardiovascular Diseases Supplements, Elsevier/French Society of Cardiology, 2016, 26es Journées européennes de la Société Française de cardiologie, 8 (1), pp.32. ⟨10.1016/S1878-6480(16)30100-8⟩, Archives of Cardiovascular Diseases Supplements, 2016, 26es Journées européennes de la Société Française de cardiologie, 8 (1), pp.32. ⟨10.1016/S1878-6480(16)30100-8⟩
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
-
Abstract
- International audience; Background Rest echocardiography plays a role in the diagnosis and risk stratification of hypertrophic cardiomyopathy (HCM). Indeed, left atrial enlargement, severe left ventricle (LV) hypertrophy and rest LV outflow tract (LVOT) gradients ≥50mmHg are sudden cardiac death risk factors as highlighted in recent guidelines. Conversely, exercise echocardiography findings play only a limited role in prognosis evaluations. Therefore, we sought to determine whether exercise induced changes in myocardial and valvular functions could improve HCM risk stratification. Methods and results Consecutive HCM patients with a preserved LV ejection fraction underwent standardized exercise echocardiography (including the assessment of myocardial function, dynamic left intra-ventricular gradient and valvular regurgitations) at baseline and were clinically followed for a median of 29.3 months. The primary endpoint was a composite criterion that included death from any cause, cardiorespiratory arrest, and hospitalization for a cardiovascular event. A total of 126 patients were included. Eighteen patients reached the primary endpoint. According to univariate Cox regression analysis, exercise LVOT gradient ≥50mmHg (HR=3.31, p=0.01) and significant (≥2/4) exercise mitral regurgitation (HR=3.64, p
- Subjects :
- Mitral regurgitation
medicine.medical_specialty
Ejection fraction
business.industry
Hypertrophic cardiomyopathy
030204 cardiovascular system & hematology
medicine.disease
3. Good health
Sudden cardiac death
Muscle hypertrophy
03 medical and health sciences
0302 clinical medicine
medicine.anatomical_structure
Ventricle
Internal medicine
cardiovascular system
Cardiology
Clinical endpoint
Left atrial enlargement
Medicine
[SDV.IB]Life Sciences [q-bio]/Bioengineering
cardiovascular diseases
030212 general & internal medicine
business
Cardiology and Cardiovascular Medicine
Subjects
Details
- ISSN :
- 18786480
- Volume :
- 8
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Archives of Cardiovascular Diseases Supplements
- Accession number :
- edsair.doi.dedup.....063fd2e9fa0fb83ffe542e8fbcd01648
- Full Text :
- https://doi.org/10.1016/s1878-6480(16)30100-8